Anti-SLC49A4 monoclonal antibody

Pre-made anti-SLC49A4 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to SLC49A4/SLC49A4 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0695-Ab-1/ GM-Tg-hg-IP0695-Ab-2Anti-Human SLC49A4 monoclonal antibodyHuman
GM-Tg-rg-IP0695-Ab-1/ GM-Tg-rg-IP0695-Ab-2Anti-Rat SLC49A4 monoclonal antibodyRat
GM-Tg-mg-IP0695-Ab-1/ GM-Tg-mg-IP0695-Ab-2Anti-Mouse SLC49A4 monoclonal antibodyMouse
GM-Tg-cynog-IP0695-Ab-1/ GM-Tg-cynog-IP0695-Ab-2Anti-Cynomolgus/ Rhesus macaque SLC49A4 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0695-Ab-1/ GM-Tg-felg-IP0695-Ab-2Anti-Feline SLC49A4 monoclonal antibodyFeline
GM-Tg-cang-IP0695-Ab-1/ GM-Tg-cang-IP0695-Ab-2Anti-Canine SLC49A4 monoclonal antibodyCanine
GM-Tg-bovg-IP0695-Ab-1/ GM-Tg-bovg-IP0695-Ab-2Anti-Bovine SLC49A4 monoclonal antibodyBovine
GM-Tg-equg-IP0695-Ab-1/ GM-Tg-equg-IP0695-Ab-2Anti-Equine SLC49A4 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0695-Ab-1/ GM-Tg-hg-IP0695-Ab-2; GM-Tg-rg-IP0695-Ab-1/ GM-Tg-rg-IP0695-Ab-2;
GM-Tg-mg-IP0695-Ab-1/ GM-Tg-mg-IP0695-Ab-2; GM-Tg-cynog-IP0695-Ab-1/ GM-Tg-cynog-IP0695-Ab-2;
GM-Tg-felg-IP0695-Ab-1/ GM-Tg-felg-IP0695-Ab-2; GM-Tg-cang-IP0695-Ab-1/ GM-Tg-cang-IP0695-Ab-2;
GM-Tg-bovg-IP0695-Ab-1/ GM-Tg-bovg-IP0695-Ab-2; GM-Tg-equg-IP0695-Ab-1/ GM-Tg-equg-IP0695-Ab-2
Products NameAnti-SLC49A4 monoclonal antibody
Formatmab
Target NameSLC49A4
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-SLC49A4 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0695-Ag-1Recombinant multi-species DIRC2/ SLC49A4/ RCC4 protein


    Target information

    Target IDGM-IP0695
    Target NameSLC49A4
    Gene ID84925,224132,303902,720996,478588,101092135,783019,100070543
    Gene Symbol and SynonymsDIRC2,RCC4,SLC49A4
    Uniprot AccessionQ96SL1,Q66H95
    Uniprot Entry NameDIRC2_HUMAN,DIRC2_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000138463
    Target ClassificationN/A

    The target: SLC49A4, gene name: SLC49A4, also named as DIRC2, RCC4. This gene encodes a membrane-bound protein from the major facilitator superfamily of transporters. Disruption of this gene by translocation has been associated with haplo-insufficiency and renal cell carcinomas. Alternatively spliced transcript variants have been described, but their biological validity has not yet been determined. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.